Wealthspire Advisors, L.P. - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 199 filers reported holding PDL BIOPHARMA INC in Q3 2016. The put-call ratio across all filers is 1.13 and the average weighting 0.0%.

Quarter-by-quarter ownership
Wealthspire Advisors, L.P. ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q1 2019$1,000
-75.0%
142
-90.2%
0.00%
Q4 2018$4,000
-20.0%
1,455
-17.0%
0.00%
Q3 2018$5,000
+25.0%
1,7540.0%0.00%
Q2 2018$4,000
-20.0%
1,7540.0%0.00%
Q1 2018$5,0000.0%1,754
-1.1%
0.00%
Q4 2017$5,000
-16.7%
1,773
-5.9%
0.00%
-100.0%
Q3 2017$6,000
+20.0%
1,884
-8.9%
0.00%0.0%
Q2 2017$5,000
+400.0%
2,068
+222.1%
0.00%
Q1 2017$1,000642
+330.9%
0.00%
Q3 2016$0149
+8.0%
0.00%
Q2 2016$0138
+45.3%
0.00%
Q1 2016$0950.00%
Other shareholders
PDL BIOPHARMA INC shareholders Q3 2016
NameSharesValueWeighting ↓
Argent Trust Co 41,405$102,2700.01%
Diversified Trust Co 11,029$26,4690.00%
HANCOCK WHITNEY CORP 128,396$00.00%
RHUMBLINE ADVISERS 612$1,5110.00%
Ancora Advisors LLC 4,948$00.00%
Westside Investment Management, Inc. 500$00.00%
View complete list of PDL BIOPHARMA INC shareholders